403 Primary results from ENGOT-Ov41/GEICO 69-O/ANITA, a double-blind placebo-controlled phase 3 trial evaluating atezolizumab combined with platinum-based chemotherapy and maintenance niraparib for recurrent ovarian cancer with a platinum-free interval >6 months
Antonio González-Martín, M. J. Rubio-Pérez, Florian Heitz, R. Christensen, N. Colombo, T. Gorp, A. Oaknin, Alexandra Leary, Lydia Gaba, C. Lebreton, Luis Miguel De Sande González, M. Romeo, A. Redondo, M. Barretina-Ginesta, Alejandro Pérez-Fidalgo, A. Santaballa, María José Bermejo, I. Bruchim, I. Ray-Coquard, Frédéric Selle
{"title":"403 Primary results from ENGOT-Ov41/GEICO 69-O/ANITA, a double-blind placebo-controlled phase 3 trial evaluating atezolizumab combined with platinum-based chemotherapy and maintenance niraparib for recurrent ovarian cancer with a platinum-free interval >6 months","authors":"Antonio González-Martín, M. J. Rubio-Pérez, Florian Heitz, R. Christensen, N. Colombo, T. Gorp, A. Oaknin, Alexandra Leary, Lydia Gaba, C. Lebreton, Luis Miguel De Sande González, M. Romeo, A. Redondo, M. Barretina-Ginesta, Alejandro Pérez-Fidalgo, A. Santaballa, María José Bermejo, I. Bruchim, I. Ray-Coquard, Frédéric Selle","doi":"10.1136/ijgc-2024-esgo.44","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"69 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Sessions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2024-esgo.44","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
